Blanket Purchase Agreement V797P2234D-HT001423A0010
Award Date 7/28/23
Last Date to Order 7/27/28
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The Defense Health Agency (DHA) has awarded a series of Blanket Purchase Agreement (BPA) call contracts to Lantheus Medical Imaging, Inc., a wholly-owned subsidiary of Lantheus Holdings, Inc. These contracts, valued at over $1 million in total ceiling, facilitate the procurement of radiopharmaceuticals, nuclear medicine supplies, and diagnostic imaging agents for military treatment facilities and other federal healthcare providers. Lantheus, a for-profit manufacturer specializing in innovative...
- The Defense Health Agency (DHA) has awarded a Blanket Purchase Agreement (BPA) to Medi-Physics, Inc., a subsidiary of General Electric Company (GE), to provide radiopharmaceuticals and supplies to military treatment facilities nationwide. The contract has a potential value of $1 million and a period of performance from October 1, 2020 through September 30, 2025. Under this BPA, Medi-Physics will deliver a range of radioactive tracers, medical isotopes, and diagnostic imaging agents used in...
- This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA), a defense agency responsible for healthcare services for the military, to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The BPA has a ceiling value of $350,000.00 and a period of performance from February 17, 2022 to February 16, 2027. It is a single-award contract that was not set aside for any specific business category. The primary purpose of this BPA is to procure NETSPOT Gallium-68...
- The Defense Health Agency awarded a single-award Blanket Purchase Agreement to Sun Pharmaceutical Industries, Inc. with a potential value of $8 million. The BPA is for the delivery of radiopharmaceutical dose products and consumables to support nuclear medicine services through January 2025. No set-asides were applied to this procurement. The original solicitation sought a contractor to provide radiopharmaceuticals and related supplies necessary for diagnostic imaging and therapeutic...
- This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency Contracting Activity (DHACA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, to procure various radiopharmaceuticals for use in the Nuclear Medicine Division at Naval Medical Center San Diego (NMCSD). The single-award, firm-fixed-price BPA is valued at $1,900,000.00 and has a performance period from October 1, 2024 to September 30, 2029. The BPA covers the acquisition of 31 different...
- Lantheus Medical Imaging, Inc., a subsidiary of Lantheus Holdings, Inc., has been awarded a Federal Supply Schedule (FSS) contract under GSA Schedule 61-IB for Pharmaceuticals and Drugs. The contract, held by the parent company Lantheus Holdings, enables Lantheus Medical Imaging to provide a wide range of specialized medical imaging products, nuclear medicine supplies, and radiopharmaceuticals to various federal healthcare agencies, including the Department of Veterans Affairs (VA), Defense...
- This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Pharmarx Hawaii LLC, a minority-owned, Asian-Pacific American, for-profit limited liability company, to provide radiopharmaceutical supplies to Tripler Army Medical Center in Hawaii. The single-award BPA has a total ceiling value of $1,250,000 and a period of performance through April 30, 2026. The contract does not utilize any set-asides. As a BPA, this vehicle allows the DHA to place task orders for...
- This Blanket Purchase Agreement (BPA) is a single award contract between the National Acquisition Center, a civilian agency, and Bausch Health US LLC, a for-profit limited liability company and manufacturer of goods. The BPA, established under the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule (FSS-61-IB), has a ceiling value of $530,000 and a period of performance through October 16, 2026. The purpose of this BPA is to provide the Department of Veterans Affairs (VA)...
- This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency to Trillamed LLC, a veteran-owned small business, to provide positron emission tomography (PET) radiopharmaceuticals to the Naval Medical Center San Diego. The $1,145,770 single-award contract has a period of performance through July 2029. Trillamed has extensive experience providing a variety of medical equipment, supplies, and related services to federal agencies, including the VA, DoD, and other healthcare...
- This Blanket Purchase Agreement (BPA) was awarded by the Defense Health Agency (DHA) to Sun Pharmaceutical Industries, Inc., a for-profit manufacturer of pharmaceutical and radiopharmaceutical products. The $250,000.00 single-award contract, which runs from June 13, 2025 to June 12, 2030, provides radiation treatment agents to the DHA. Sun Pharmaceutical Industries, Inc. is a well-established federal contractor that specializes in nuclear medicine imaging products and radiopharmaceutical dose...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
BPA Call HT001423A0010-HT001425F0051 | Lantheus Medical Imaging, Inc. | $0 | 5/30/25 | 5/30/25 | 5/9/25 |